Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
Research shows that smoking cessation is the most significant preventable health behavior
change that a person can make to lower cancer risk. In addition, telephone quitlines are an
effective, science-based smoking cessation treatment that is universally accessible to
smokers in the U.S. However, little research has explored promising approaches that could
increase quitline use, improve quit rates, and inform resource allocation for quitline
services. The proposed study will test three promising enhancements to the standard quitline
treatment that typically consists of counseling and, possibly 2 weeks of a NRT medication.
These enhancements are: 1) combination nicotine replacement therapy as recommended by the
United States Public Health Service Clinical Practice Guideline on Treating Tobacco Use and
Dependence; 2) extended duration of cessation medication use; and 3) an innovative counseling
addition - cognitive medication adherence counseling - to optimize adherence to cessation
medication. In addition, the cost-effectiveness of each intervention will be calculated. The
findings of the proposed research have broad potential application and relevance to state
quitlines, quitline service providers, and other purchasers of quitline services such as
employers and insurers. Additionally, the study findings can potentially inform other
telephone health behavior counseling programs.
Phase:
Phase 4
Details
Lead Sponsor:
University of Wisconsin, Madison
Collaborators:
Alere Wellbeing Consumer Wellness Solutions Department of Health and Human Services National Cancer Institute (NCI) Wisconsin Department of Health and Family Services